TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Barbara Linder, MD PhD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Director - David Nathan, MD
Massachusetts General Hospital
Principal Investigator - Jane Lynch, MD
The University of Texas Health Science Center at San Antonio
Principal Investigator - Kathryn Hirst, PhD
George Washington University
Principal Investigator - Ken Copeland, MD
University of Oklahoma Health Science Center
Principal Investigator - Leona Cuttler, MD
CWRU Rainbow Babies and Children's Hospital
Principal Investigator - Lori Laffel, MD
Joslin Diabetes Center
Principal Investigator - Lorraine Katz, MD
Children's Hospital of Philadelphia
Principal Investigator - Mitch Geffner, MD
Children's Hospital Los Angeles
Principal Investigator - Neil White, MD
Washington University School of Medicine
Principal Investigator - Phil Zeitler, MD PhD
University of Colorado, Denver
Study Chair - Robin Goland, MD
Columbia University Naomi Berrie Diabetes Center
Principal Investigator - Ruth Weinstock, MD PhD
State University of New York - Upstate Medical University
Principal Investigator - Sherida Tollefsen, MD
Saint Louis University Health Sciences Center
Principal Investigator - Silva Arslanian, MD
University of Pittsburgh
Principal Investigator - Siripoom McKay, MD
Baylor College of Medicine
Principal Investigator - Sonia Caprio, MD
Yale University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- University of Colorado Denver
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- George Washington University Biostatistics Center
Rockville, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Massachusetts General Hospital Diabetes Center
Boston, Massachusetts, United States
- Saint Louis University
St Louis, Missouri, United States
- Washington University
St Louis, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- State University of New York Upstate Medical University
Syracuse, New York, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Children'S Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2011
- Primary completion
- 28 Feb 2014
- Completion
- 28 Feb 2014
- Last update posted
- 4 Aug 2021
- Registered enrollment
- 550
- Registry id
- NCT01364350
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.